By reading the full text of the remaining 49 articles, 14 were excluded in which the comparison set of 12 trials did not meet the inclusion criteria, and 2 were quasi-climacteric syndrome caused by Aromatase Inhibitors treatment. The gene discussed is CYP19A1; the disease is Down syndrome.